ACS Nano 17 (22), 2233422354
Latest news '2026-07-21T11:35:00Z' | dateFormatFilter Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Lilly '2026-07-15T15:51:00Z' | dateFormatFilter Novo Nordisk receives European Commission approval of Wegovy pill as first oral GLP-1 for weight management in the EU
By reducing the chronic workload on the pancreas through DPP-4 inhibition, scientists are studying whether early use can slow the natural decline of insulin-producing cells
10.1038/s41389-020-00273-z 22 ChenY
Las personas con hipertensin, diabetes, nefropata o enfermedad heptica por alcoholismo tambin deberan consultar a un especialista antes de empezar a consumir este tipo de suplementos
[DOI] [PubMed] [Google Scholar] 107.Lee H.J., Kim S.R., Kim J.C., Kang C.M., Lee Y.S., Jo S.K., Kim T.H., Jang J.S., Nah S.Y., Kim S.H